Editorial

Repeated Stool Toxin Testing for Diagnosing Difficile Colitis Is Still Valid

Authors: Ziad Arabi MD, Asgar Boxwalla MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Gade RL, Turett G. The utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis. South Med J 2009;102:1007–1009.GadeRL]]TurettGThe utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis.South Med J20091021007-10092. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46:S12–S18.BartlettJG]]GerdingDNClinical recognition and diagnosis of Clostridium difficile infection.Clin Infect Dis200846S12-S183. Kyne L, Hamel MB, Polavaram R, et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346–353.KyneL]]HamelMB]]PolavaramR&etal;Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.Clin Infect Dis200234346-3534. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium Difficile—Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340–343.Centers for Disease Control and Prevention (CDC)Surveillance for community-associated Clostridium Difficile—Connecticut, 2006.MMWR Morb Mortal Wkly Rep200857340-3435. Centers for Disease Control and Prevention (CDC). Update: influenza activity—United States, September 28, 2008-April 4, 2009, and composition of the 2009–10 influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:369–374.Centers for Disease Control and Prevention (CDC)Update: influenza activity—United States, September 28, 2008-April 4, 2009, and composition of the 2009–10 influenza vaccine.MMWR Morb Mortal Wkly Rep200958369-3746. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273–280.MutoCA]]PokrywkaM]]ShuttK&etal;A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.Infect Control Hosp Epidemiol200526273-2807. Cober ED, Malani PN. Clostridium difficile infection in the “oldest” old: clinical outcomes in patients aged 80 and older. J Am Geriatr Soc 2009;57:659–662.CoberED]]MalaniPNClostridium difficile infection in the “oldest” old: clinical outcomes in patients aged 80 and older.J Am Geriatr Soc200957659-6628. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000–2005. Emerg Infect Dis 2008;14:929–931.ZilberbergMD]]ShorrAF]]KollefMHIncrease in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000–2005.Emerg Infect Dis200814929-9319. Debast SB, van Kregten E, Oskam KM, et al. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease. Clin Microbiol Infect 2008;14:622–624.DebastSB]]van KregtenE]]OskamKM&etal;Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease.Clin Microbiol Infect200814622-62410. Nemat H, Khan R, Ashraf MS, et al. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am J Gastroenterol. 2009;104:2035–2041.NematH]]KhanR]]AshrafMS&etal;Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.Am J Gastroenterol20091042035-204111. Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol 2008;46:3686–3689.CardonaDM]]RandKHEvaluation of repeat Clostridium difficile enzyme immunoassay testing.J Clin Microbiol2008463686-368912. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993;269:71–75.FeketyR]]ShahABDiagnosis and treatment of Clostridium difficile colitis.JAMA199326971-7513. Kirkpatrick ID, Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? AJR Am J Roentgenol 2001;176:635–639.KirkpatrickID]]GreenbergHMEvaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?AJR Am J Roentgenol2001176635-63914. O’Brien JA, Lahue BJ, Caro JJ, et al. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219–1227.O’BrienJA]]LahueBJ]]CaroJJ&etal;The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.Infect Control Hosp Epidemiol2007281219-1227